Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06466005 · ClinicalTrials.gov registry record
UnityPhilly Response App for Overdose Reversal
A clinical trial, sponsored by Drexel University.
- Recruiting
- Registry status
- 450
- Enrollment target
NCT06466005 is a clinical trial that is actively recruiting participants, run by Drexel University. The registered enrollment target is 450 participants.
The verdict
NCT06466005 is actively recruiting participants, sponsored by Drexel University.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to discover if an overdose prevention app (UnityPhilly) can encourage citizen responders to respond and prevent opioid overdoses using the UnityPhilly app. The main hypotheses to answer are: Hypothesis 1: UnityPhilly signal rates relative to EMS calls will increase over time. The primary outcome will be assessed as the total number of overdoses signaled by participants relative to all overdose-related EMS calls, per year. Hypothesis 2: The number of cases where a nearby UnityPhilly participant successfully reverses an overdose with naloxone will increase over time. The primary outcome will be assessed as the number of successful reversals relative to the total number of responder arrivals, per year. Participants will be supplied with the UnityPhilly app, training on how to use the app and respond to an opioid overdose using naloxone, and respond to follow up surveys about their experiences.
Interventions
- OTHER UnityPhilly app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2025-09-16 |
| Est. Completion | 2028-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06466005
The ClinicalTrials.gov registry entry for NCT06466005 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UnityPhilly app is the first listed.
NCT06466005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06466005 about?
NCT06466005 is a clinical study titled "UnityPhilly Response App for Overdose Reversal". The goal of this clinical trial is to discover if an overdose prevention app (UnityPhilly) can encourage citizen responders to respond and prevent opioid overdoses using the UnityPhilly app. The main hypotheses to answer are: Hypothesis 1: UnityPhilly signal rates relative to EMS calls will increas...
What is the current status of trial NCT06466005?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2025-09-16. Estimated completion is 2028-07.
What interventions are being tested in trial NCT06466005?
The interventions under investigation include: UnityPhilly app (OTHER).
Who is sponsoring clinical trial NCT06466005?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.